These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34599598)

  • 1. Systemic sclerosis in Hispanics: cutaneous salt and pepper lesions.
    Ocampo-Candiani J; Suro-Santos Y; Villarreal-Martinez A; Herz-Ruelas ME; Galarza-Delgado DA; Hernandez-Galarza IJ; Villareal-Alarcon MA; Flores-Alvarado DE; Gomez-Flores M; Vazquez-Martinez OT; Chavez-Alvarez S
    Int J Dermatol; 2022 Mar; 61(3):e94-e96. PubMed ID: 34599598
    [No Abstract]   [Full Text] [Related]  

  • 2. ["Salt and pepper" sign in systemic sclerosis].
    Krauß M; Kreuter A; Matull J
    Dermatologie (Heidelb); 2024 Feb; 75(2):147. PubMed ID: 38189828
    [No Abstract]   [Full Text] [Related]  

  • 3. Salt-and-pepper skin appearance and systemic sclerosis.
    Sakamoto T; Kaburaki M; Shimizu T
    QJM; 2021 Nov; 114(8):599-600. PubMed ID: 33956977
    [No Abstract]   [Full Text] [Related]  

  • 4. Expression of MMP-9 and TIMP-1 in lesions of systemic sclerosis and its implications.
    Meng C; Chen X; Li J; Wu Y; Liu H
    J Huazhong Univ Sci Technolog Med Sci; 2008 Aug; 28(4):480-2. PubMed ID: 18704317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salt-and-pepper appearance with supravenous pigment retention in systemic sclerosis.
    Yin H; Lu L
    Clin Exp Dermatol; 2022 Jul; 47(7):1359-1360. PubMed ID: 35262233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salt and pepper appearance in systemic sclerosis.
    Chandra A; Sil A; Hati A; Shah KA
    QJM; 2022 Jan; 115(1):41-42. PubMed ID: 34694394
    [No Abstract]   [Full Text] [Related]  

  • 7. Salt-and-Pepper Skin Changes in Systemic Sclerosis.
    Colquhoun M; Penn H
    N Engl J Med; 2021 Jul; 385(4):357. PubMed ID: 34289279
    [No Abstract]   [Full Text] [Related]  

  • 8. Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.
    Ferreli C; Gasparini G; Parodi A; Cozzani E; Rongioletti F; Atzori L
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):306-336. PubMed ID: 28712039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New-Onset Salt-and-Pepper Skin Changes Associated With Vaccination and Trauma in Systemic Sclerosis: Immunity Matters.
    Yin H; Lu L
    J Rheumatol; 2022 Dec; 49(12):1404-1405. PubMed ID: 36455934
    [No Abstract]   [Full Text] [Related]  

  • 10. Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis.
    Falanga V; Medsger TA
    J Am Acad Dermatol; 1987 Oct; 17(4):648-56. PubMed ID: 3668010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis.
    Giordano M; Valentini G; Migliaresi S; Picillo U; Vatti M
    J Rheumatol; 1986 Oct; 13(5):911-6. PubMed ID: 3546686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sine Scleroderma.
    Kaur G; Banka S; Meena B; Kulkarni A; Prajapat R; Dhaka J
    J Assoc Physicians India; 2020 Apr; 68(4):68-70. PubMed ID: 32610852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic sclerosis sine scleroderma.
    Kucharz EJ; Kopeć-Mędrek M
    Adv Clin Exp Med; 2017 Aug; 26(5):875-880. PubMed ID: 29068586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous and subcutaneous inflammatory sclerosis syndromes.
    Doyle JA; Connolly SM; Winkelmann RK
    Arch Dermatol; 1982 Nov; 118(11):886-90. PubMed ID: 7138043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive systemic sclerosis sine scleroderma presenting as pulmonary interstitial fibrosis.
    Lomeo RM; Cornella RJ; Schabel SI; Silver RM
    Am J Med; 1989 Nov; 87(5):525-7. PubMed ID: 2683765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localized and systemic scleroderma.
    Hawk A; English JC
    Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Central Corneal Thickness in Different Subtypes of Systemic Sclerosis.
    Gomes BA; Santhiago MR; Kara-Junior N; de Azevedo MN; Moraes HV
    Ocul Immunol Inflamm; 2016 Dec; 24(6):693-698. PubMed ID: 26652214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [How to evaluate prospectively cutaneous sclerosis in systemic scleroderma?].
    Francès C
    Ann Med Interne (Paris); 1992; 143(8):503-4. PubMed ID: 1303591
    [No Abstract]   [Full Text] [Related]  

  • 19. Histological and rheological grading of cutaneous sclerosis in scleroderma.
    Piérard GE
    Dermatologica; 1989; 179(1):18-20. PubMed ID: 2767293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies.
    Fett N
    Clin Dermatol; 2013; 31(4):432-437. PubMed ID: 23806160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.